Jane Street Group LLC Sells 22,834 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Jane Street Group LLC reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 11.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 171,851 shares of the company’s stock after selling 22,834 shares during the quarter. Jane Street Group LLC owned about 0.10% of Option Care Health worth $3,987,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Murphy & Mullick Capital Management Corp bought a new stake in shares of Option Care Health in the 4th quarter valued at about $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC increased its stake in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in shares of Option Care Health in the 4th quarter valued at about $47,000. 98.05% of the stock is owned by institutional investors.

Insider Transactions at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on OPCH. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Finally, UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Trading Up 0.4%

NASDAQ:OPCH opened at $31.84 on Monday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a 50 day moving average price of $33.24 and a two-hundred day moving average price of $28.89. The company has a market cap of $5.21 billion, a P/E ratio of 26.76, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the firm posted $0.26 EPS. The business’s revenue was up 16.3% on a year-over-year basis. As a group, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.